[HTML][HTML] CCL5/CCR5 axis in human diseases and related treatments

Z Zeng, T Lan, Y Wei, X Wei - Genes & diseases, 2022 - Elsevier
To defense harmful stimuli or maintain the immune homeostasis, the body produces and
recruits a superfamily of cytokines such as interleukins, interferons, chemokines etc. Among …

The roles of CCR9/CCL25 in inflammation and inflammation-associated diseases

X Wu, M Sun, Z Yang, C Lu, Q Wang… - Frontiers in cell and …, 2021 - frontiersin.org
Chemokine is a structure-related protein with a relatively small molecular weight, which can
target cells to chemotaxis and promote inflammatory response. Inflammation plays an …

CCL13 and human diseases

L Li, F Dai, L Wang, Y Sun, L Mei, Y Ran… - Frontiers in …, 2023 - frontiersin.org
CCL13/MCP-4 belongs to the CC chemokine family, which induces chemotaxis in many
immune cells. Despite extensive research into its function in numerous disorders, a thorough …

Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders

L Fantuzzi, M Tagliamonte, MC Gauzzi… - Cellular and molecular life …, 2019 - Springer
The chemokine system mediates acute inflammation by driving leukocyte migration to
damaged or infected tissues. However, elevated expression of chemokines and their …

CCR6-CCL20 axis as a therapeutic target for autoimmune diseases

HT Meitei, N Jadhav, G Lal - Autoimmunity reviews, 2021 - Elsevier
Chemokine receptor CCR6 is expressed on various cells such as B cells, immature dendritic
cells, innate lymphoid cells (ILCs), regulatory CD4 T cells, and Th17 cells. CCL20 is the only …

CCR5 is a potential therapeutic target for cancer

H Hemmatazad, MD Berger - Expert opinion on therapeutic targets, 2021 - Taylor & Francis
Introduction Chemokines and their cognate receptors play a major role in modulating
inflammatory responses. Depending on their ligand binding, chemokine receptors can …

New insights of CCR7 signaling in dendritic cell migration and inflammatory diseases

W Hong, B Yang, Q He, J Wang, Q Weng - Frontiers in pharmacology, 2022 - frontiersin.org
CCR7, collaborated with its ligands CCL19 and CCL21, controls extensive migratory events
in the immune system. CCR7-bearing dendritic cells can swarm into T-cell zones in lymph …

Modulation of the CCR6-CCL20 axis: a potential therapeutic target in inflammation and cancer

R Ranasinghe, R Eri - Medicina, 2018 - mdpi.com
Prototypical functions of the chemokine receptor CCR6 include immune regulation by
maneuvering cell chemotaxis and selective delimiting of the pro-inflammatory TH17 and …

Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table

M Ranjbar, A Rahimi, Z Baghernejadan… - International …, 2022 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is cause of the novel
coronavirus disease (COVID-19). In the last two years, SARS-CoV-2 has infected millions of …

The multiple faces of CCL13 in immunity and inflammation

E Mendez-Enriquez, EA García-Zepeda - Inflammopharmacology, 2013 - Springer
Abstract CCL13/MCP-4, is a CC family chemokine that is chemoattractant for eosinophils,
basophils, monocytes, macrophages, immature dendritic cells, and T cells, and its capable …